Quest Diagnostics, Inc. (DGX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Quest Diagnostics, Inc. (DGX)
Company Performance

Current Price

as of Dec 04, 2024

$160.24

P/E Ratio

21.51

Market Cap

$17.89B

Description

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Metrics

Overview

  • HQSecaucus, NJ
  • SectorHealth Services
  • IndustryServices to the Health Industry
  • TickerDGX
  • Price$160.24-1.05%

Trading Information

  • Market cap$17.89B
  • Float99.50%
  • Average Daily Volume (1m)861,863
  • Average Daily Volume (3m)795,202
  • EPS$7.52

Company

  • Revenue$9.54B
  • Rev growth (1yr)8.41%
  • Net income$225.00M
  • Gross margin31.51%
  • EBITDA margin19.09%
  • EBITDA$475.00M
  • EV$23.86B
  • EV/Revenue2.50
  • P/E21.51
  • P/S1.90
  • P/B2.64
Documents
SEC Filings
8-K (2024-10-22)
8-K (2024-08-29)
8-K (2024-08-19)
8-K (2024-07-23)
8-K (2024-07-03)
8-K (2024-05-21)
8-K (2024-04-23)
8-K (2024-02-01)
8-K (2023-11-01)
8-K (2023-10-24)
8-K (2023-09-29)
8-K (2023-07-26)
8-K (2023-05-19)
8-K (2023-04-27)
8-K (2023-03-17)
8-K (2023-03-07)
8-K (2023-02-02)
10-Q (2024-10-23)
10-Q (2024-07-24)
10-Q (2024-04-24)
10-Q (2023-10-25)
10-Q (2023-07-27)
10-Q (2023-04-28)
10-K (2024-02-22)
10-K (2023-02-21)
Factset Street Account
StreetAccount Metrics Recap - Quest Diagnostics Q3 Earnings ($121.45, 0.00) (2023-10-24T10:51:48Z)
StreetAccount Earnings Call Q&A Summary: Quest Diagnostics Q3 (2023-10-24T14:07:35Z)
Quest Diagnostics reports Q3 EPS $2.22 ex-items vs FactSet $2.19 [15 est, $2.09-2.24] ($121.45, 0.00) (2023-10-24T10:47:26Z)
Quest Diagnostics and Scipher Medicine collaborate to scale precision medicine access for patients with rheumatoid arthritis ($135.31, 0.00) (2023-11-28T13:48:40Z)
Quest Diagnostics and Scipher Medicine collaborate to scale precision medicine access for patients with rheumatoid arthritis ($134.91, -0.91) (2023-12-19T15:49:31Z)
Diadem SpA announces exclusive U.S. licensing agreement with Quest Diagnostics for Its AlzoSure Predict Alzheimer's disease prognostic technology ($123.58, 0.00) (2023-10-25T11:04:52Z)
Earnings Calls
Earnings Report 2024Q3
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report (2023-10-24)
Factset
Factset Business Description
Wikipedia
Quest_Diagnostics_Inc